Innovate Biopharmaceuticals, Inc. (INNT): Price and Financial Metrics
INNT Price/Volume Stats
Current price | $0.56 | 52-week high | $1.67 |
Prev. close | $0.70 | 52-week low | $0.37 |
Day low | $0.55 | Volume | 1,547,700 |
Day high | $0.72 | Avg. volume | 525,982 |
50-day MA | $0.52 | Dividend yield | N/A |
200-day MA | $0.77 | Market Cap | 23.14M |
INNT Stock Price Chart Interactive Chart >
Innovate Biopharmaceuticals, Inc. (INNT) Company Bio
Innovate Biopharmaceuticals, Inc., a clinical stage biotechnology company, focuses on developing autoimmune and inflammation therapeutics. Its late-stage clinical pipeline focuses on addressing unmet needs in diseases, such as celiac disease, inflammatory bowel disease (IBD), and nonalcoholic steatohepatitis (NASH). The company's lead drug candidate, larazotide acetate (INN-202), has successfully met its primary endpoint in a Phase 2b efficacy clinical trial for celiac disease. It is also developing INN-108, which is entering into Phase 2 clinical trials for the treatment of mild to moderate ulcerative colitis. In addition, the company owns the global rights to INN-329, a proprietary formulation of secretin, a peptide hormone used to enhance visualization in magnetic resonance cholangiopancreatography procedures. Innovate Biopharmaceuticals, Inc. was founded in 2012 and is based in Raleigh, North Carolina.
INNT Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | N/A |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...